Add to ORKGfor treatment and prevention of osteoporosis, has been shown in several clinical trials to reduce the risk of fractures in postmenopausal women with osteoporosis. The cost-effectiveness of risedronate treatment ha
OBJECTIVES: To assess the incremental cost-effectiveness ratio (ICER) and incremental cost-utility r...
peer reviewedSummary. The use of gastro-resistant risedronate, a convenient dosing regimen for oral ...
what hip fracture risk is it cost-effective to treat? International intervention thresholds for the ...
Abstract: Objective: Osteoporosis is a major public health concern in Switzerland and is associated ...
Randomized, double-blind, controlled studies have shown that treatment with risedronate reduces the ...
Introduction: Risedronate, a bisphosphonate for treatment and prevention of osteoporosis, has been s...
46268, USAOsteoporosis is a common disease that is characterized by a significant loss of bone mass....
Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes a pe...
Summary The cost-effectiveness of strontium ranelate was compared to no treatment in UK women using ...
The study estimated the cost-effectiveness of risedronate compared to no treatment in UK women using...
Summary Diagnosis and treatment of osteoporosis in hospitals is poor. We compared patient outcomes b...
Copyright © 2014 Chiara de Waure et al. This is an open access article distributed under the Creativ...
Osteoporosis and subsequent fractures is a rapidly growing major health problem in many parts of the...
Tahir Masud1, Michael McClung2, Piet Geusens31Nottingham University Hospitals NHS Trust, Nottin...
Background: Osteoporosis has a huge impact on public health, through the increased morbidity, mortal...
OBJECTIVES: To assess the incremental cost-effectiveness ratio (ICER) and incremental cost-utility r...
peer reviewedSummary. The use of gastro-resistant risedronate, a convenient dosing regimen for oral ...
what hip fracture risk is it cost-effective to treat? International intervention thresholds for the ...
Abstract: Objective: Osteoporosis is a major public health concern in Switzerland and is associated ...
Randomized, double-blind, controlled studies have shown that treatment with risedronate reduces the ...
Introduction: Risedronate, a bisphosphonate for treatment and prevention of osteoporosis, has been s...
46268, USAOsteoporosis is a common disease that is characterized by a significant loss of bone mass....
Osteoporosis is a skeletal disorder characterized by compromised bone strength that predisposes a pe...
Summary The cost-effectiveness of strontium ranelate was compared to no treatment in UK women using ...
The study estimated the cost-effectiveness of risedronate compared to no treatment in UK women using...
Summary Diagnosis and treatment of osteoporosis in hospitals is poor. We compared patient outcomes b...
Copyright © 2014 Chiara de Waure et al. This is an open access article distributed under the Creativ...
Osteoporosis and subsequent fractures is a rapidly growing major health problem in many parts of the...
Tahir Masud1, Michael McClung2, Piet Geusens31Nottingham University Hospitals NHS Trust, Nottin...
Background: Osteoporosis has a huge impact on public health, through the increased morbidity, mortal...
OBJECTIVES: To assess the incremental cost-effectiveness ratio (ICER) and incremental cost-utility r...
peer reviewedSummary. The use of gastro-resistant risedronate, a convenient dosing regimen for oral ...
what hip fracture risk is it cost-effective to treat? International intervention thresholds for the ...